Preclinical analysis of liver-targeted, mild mitochondrial protonophores for treatment of non-alcoholic fatty liver disease and steatohepatitis

被引：0
|
作者：
Hansson, Magnus [1 ,2 ]
Moss, Steven [3 ]
Piel, Sarah [1 ,2 ]
Chamkha, Imen [1 ,2 ]
Gronberg, Alvar [1 ]
Gregory, Matthew [3 ]
Elmer, Eskil [1 ,2 ]
机构：
[1] NeuroVive Pharmaceut AB, Lund, Sweden
[2] Lund Univ, Dept Clin Sci, Mitochondrial Med, Lund, Sweden
[3] Isomerase Therapeut, Cambridge, England
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1982
引用
收藏
页码：1050A / 1050A
页数：1
相关论文
共 50 条
  • [21] Preclinical models of non-alcoholic fatty liver disease
    Santhekadur, Prasanna K.
    Kumar, Divya P.
    Sanyal, Arun J.
    JOURNAL OF HEPATOLOGY, 2018, 68 (02) : 230 - 237
  • [22] A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
    Ganguli, Surosree
    DeLeeuw, Peter
    Satapathy, Sanjaya K.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2019, 11
  • [23] Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models
    Nachit, Maxime
    De Rudder, Maxime
    Thissen, Jean-Paul
    Schakman, Olivier
    Bouzin, Caroline
    Horsmans, Yves
    Vande Velde, Greetje
    Leclercq, Isabelle Anne
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (01) : 144 - 158
  • [24] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
    Tacke, Frank
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [25] An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Marin, Veronica
    Rosso, Natalia
    Dal Ben, Matteo
    Raseni, Alan
    Boschelle, Manuela
    Degrassi, Cristina
    Nemeckova, Ivana
    Nachtigal, Petr
    Avellini, Claudio
    Tiribelli, Claudio
    Gazzin, Silvia
    PLOS ONE, 2016, 11 (07):
  • [26] Predictors of non-alcoholic steatohepatitis and fibrosis in non-alcoholic fatty liver disease.
    Pong, JP
    Elariny, H
    Younoszai, A
    HEPATOLOGY, 2002, 36 (04) : 407A - 407A
  • [27] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    Current HIV/AIDS Reports, 2017, 14 : 47 - 53
  • [28] Mitochondrial-Targeted Antioxidant Treatment in a Mouse Model of Non-Alcoholic Fatty Liver Disease
    Thompson, Michael
    Cismowski, Mary
    Bid, Hemant
    Lucchesi, Pamela
    FASEB JOURNAL, 2015, 29
  • [29] THE ROLE OF BLOOD GROUPS IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS
    Karagoz, Hatice
    Erden, Abdulsamet
    Ozer, Ozerhan
    Cetinkaya, Ali
    Avci, Deniz
    Gencer, Vedat
    Arik, Ferhat
    Kalan, Ugur
    Gorkem, Hasan
    Karaman, Hatice
    Karaman, Ahmet
    ACTA MEDICA MEDITERRANEA, 2017, 33 (02): : 205 - 210
  • [30] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
12345